Bronho-waksom adult

Roman name

Broncho-Vaxom adults

Characteristics

Liofilizat bacterial lizatov.

Clinical pharmacology

Clinically drug reduces the frequency of acute infections, reduces the length of the course and reduces the severity of symptoms, as well as reducing the risk of complications of chronic diseases. In doing so, reduce the need for the application of other property, especially antibiotics.

Indications

Prevention retidiviruta respiratory tract infections and exacerbations of chronic bronchitis; Integrated treatment of acute respiratory infections.

Pregnancy and lactation

The reproduction in animals have found no risk to the fetus, but controlled studies in pregnant women have not been carried out. For breastfeeding specific studies have been conducted, and information on the subject is not currently available.

Contraindications

Hypersensitivity to components of the preparation.

Side-Effects

Frequency slabovrajennykh adverse events 3-4%. Manifested in the form of gastrointestinal disorders (nausea, stomachache, vomiting), skin reactions (including erythemal, skin), of the respiratory system (cough, wheeze), as well as headaches, feelings of fatigue.

Patient interaction

Interaction with other network so far has been established. The drug can be used in conjunction with other PP applicable therapy for respiratory diseases.

Overdosing

The overdose cases non-existent. Nature preparation and the results of the tests of its toxicity conducted on animals suggest that the overdose unlikely.

Precautions

Based on the information available to appoint children up to six months is not recommended, due to immaturity of their immune system. To avoid an overdose of the children should not be used in drug capsules, intended for the case Vesroslah.v continuing gastrointestinal disorders, skin and respiratory manifestations must stop treatment and consult with a physician, because they can be symptoms of allergic reactions.

Storage conditions

In dry, the dark place at a temperature of 15-25 ° C

Shelf life

5 years

The registration

011540/01-1999

Directory → Immunotropona funds → Immunomodulators → Bronho-waksom adult